JP2005232094A - Ozone dissolved glycerol solution, ozone dissolved glycerol solidified material and ozone dissolved mixed solution, method for producing ozone dissolved glycerol solution, method for producing ozone dissolved mixed solution and method for preserving ozone dissolved glycerol solution - Google Patents

Ozone dissolved glycerol solution, ozone dissolved glycerol solidified material and ozone dissolved mixed solution, method for producing ozone dissolved glycerol solution, method for producing ozone dissolved mixed solution and method for preserving ozone dissolved glycerol solution Download PDF

Info

Publication number
JP2005232094A
JP2005232094A JP2004044088A JP2004044088A JP2005232094A JP 2005232094 A JP2005232094 A JP 2005232094A JP 2004044088 A JP2004044088 A JP 2004044088A JP 2004044088 A JP2004044088 A JP 2004044088A JP 2005232094 A JP2005232094 A JP 2005232094A
Authority
JP
Japan
Prior art keywords
ozone
dissolved
solution
concentration
ozone dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004044088A
Other languages
Japanese (ja)
Other versions
JP4677192B2 (en
JP2005232094A5 (en
Inventor
Akihiko Shiba
▲あき▼彦 芝
Gotaro Shioda
剛太郎 塩田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VMC Co Ltd
Original Assignee
VMC Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VMC Co Ltd filed Critical VMC Co Ltd
Priority to JP2004044088A priority Critical patent/JP4677192B2/en
Priority to TW094104998A priority patent/TW200603819A/en
Priority to PCT/JP2005/002570 priority patent/WO2005079818A1/en
Publication of JP2005232094A publication Critical patent/JP2005232094A/en
Publication of JP2005232094A5 publication Critical patent/JP2005232094A5/ja
Application granted granted Critical
Publication of JP4677192B2 publication Critical patent/JP4677192B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To prepare an ozone dissolved glycerol solution and an ozone dissolved mixed solution keeping ozone concentration enough to exhibit sterilization effect and wound-healing effect for a long period and not generating harmful oxide (peroxide). <P>SOLUTION: The ozone dissolved glycerol solution can keep ozone concentration enough to exhibit sterilization effect for a long period, because ozone is dissolved in an amount of ≥400 ppm in ≥75% nonoxidative glycerol solution. Irritation due to glycerol can be suppressed by mixing the ozone dissolved glycerol solution with either one of vaseline and polyethylene glycol. The ozone dissolved mixed solution not losing oxidative force and not containing harmful oxide (peroxide) can be produced by mixing the ozone dissolved glycerol solution with either one of water, vaseline and polyethylene glycol under stirring. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、オゾン溶存グリセリン溶液、オゾン溶存グリセリン固化物、オゾン溶存混合溶液、オゾン溶存グリセリン溶液の製造方法、オゾン溶存混合溶液の製造方法、及びオゾン溶存グリセリン溶液の保存方法に関する。   The present invention relates to an ozone-dissolved glycerin solution, an ozone-dissolved glycerin solidified product, an ozone-dissolved mixed solution, a method for producing an ozone-dissolved glycerin solution, a method for producing an ozone-dissolved mixed solution, and a method for storing an ozone-dissolved glycerin solution.

オゾンには強力な酸化作用があり、殺菌に役立つことが各種研究により実証されている。気体のオゾンの一般的な製造方法としては、空気に放電して一部をオゾン化する方法がある。   Various studies have demonstrated that ozone has a strong oxidizing action and is useful for sterilization. As a general method for producing gaseous ozone, there is a method in which a part is ozonized by discharging to air.

また、気体のオゾンの他に、オゾンを水に溶け込ませたオゾン水も利用されている。オゾン水の製造方法としては、空気を放電して製造したオゾンを何らかの方法で水に溶かし込む方法や、白金等のオゾン生成触媒機能を有する電極を用いて水を直接電気分解し、発生する酸素の一部をオゾン化し、即座に水に溶け込ませるものがある。   In addition to gaseous ozone, ozone water in which ozone is dissolved in water is also used. Ozone water is produced by a method of dissolving ozone produced by discharging air into water by some method, or by directly electrolyzing water using an electrode having an ozone generation catalyst function, such as platinum, to generate oxygen. Some of them are ozonized and immediately dissolved in water.

この他に、濃度0.01〜500ppmのオゾンを含む気体をオゾン発生器で発生させ、これを粘度が1〜106Pa・sの液体に溶解またはマイクロバブル化して封入したオゾン封入粘稠体が知られている。気体のオゾンやオゾン水には定着性がないため、用途が限られていたが、オゾン封入粘稠体により、クリームやペーストとして特定の部位に定着させオゾンを作用させることができる(特許文献1参照)。
特開平10−139645号公報
In addition, a gas containing ozone having a concentration of 0.01 to 500 ppm is generated by an ozone generator, and dissolved or microbubbled into a liquid having a viscosity of 1 to 10 6 Pa · s, and sealed into an ozone-containing viscous body. It has been known. Gaseous ozone and ozone water have no fixability, so their use has been limited. However, ozone can be fixed to a specific site as a cream or paste by using ozone-containing viscous material (Patent Document 1). reference).
Japanese Patent Laid-Open No. 10-139645

ところで、オゾン封入粘稠体を実際に殺菌剤として使用する創傷部位には、オゾンを使用する被酸化物(有機物、血液等)が多数存在するため、高濃度のオゾンが溶存している必要があり、終濃度で80ppm程度のオゾン濃度が必要である。しかし、上記のオゾン封入粘稠体では、濃度0.01〜500ppmのオゾンを含む気体を、粘度が1〜106Pa・sの液体に溶解またはマイクロバブル化して封入するため、オゾンの終濃度が極めて低くなり、実用に適したものとなっていなかった。 By the way, since there are many oxides (organic matter, blood, etc.) that use ozone in the wound site that actually uses the ozone-containing viscous material as a bactericidal agent, it is necessary that high-concentration ozone is dissolved. Yes, an ozone concentration of about 80 ppm is required as the final concentration. However, in the above ozone-sealed viscous body, a gas containing ozone having a concentration of 0.01 to 500 ppm is dissolved or microbubbled in a liquid having a viscosity of 1 to 10 6 Pa · s. Was extremely low and was not suitable for practical use.

また、オゾン封入粘稠体の製造直後のオゾン濃度が低い場合には、保管期間が長くなるとオゾン濃度が低下し、殺菌効果を維持することができなかった。また、粘稠体の種類によっては、オゾンに酸化されて有害な酸化物(過酸化物)が生じる恐れもあった。   Moreover, when the ozone concentration immediately after manufacture of an ozone enclosure viscous body is low, when the storage period became long, ozone concentration fell and it was not able to maintain the bactericidal effect. Further, depending on the type of the viscous material, there is a possibility that a harmful oxide (peroxide) is generated by being oxidized by ozone.

本発明の課題は、殺菌効果及び創傷治癒効果を発揮するのに充分なオゾン濃度を長期間維持するとともに、有害な酸化物(過酸化物)が生じないオゾン溶存グリセリン溶液、オゾン溶存グリセリン固化物、オゾン溶存混合溶液、オゾン溶存グリセリン溶液の製造方法、オゾン溶存混合溶液の製造方法、及びオゾン溶存グリセリン溶液の保存方法を提供することである。   An object of the present invention is to maintain an ozone concentration sufficient to exert a bactericidal effect and a wound healing effect for a long period of time, and an ozone-dissolved glycerin solution and an ozone-dissolved glycerin solidified product that do not generate harmful oxides (peroxides). An ozone-dissolved mixed solution, a method for producing an ozone-dissolved glycerin solution, a method for producing an ozone-dissolved mixed solution, and a method for storing an ozone-dissolved glycerin solution.

以上の課題を解決するため、請求項1に記載の発明は、オゾン溶存グリセリン溶液であって、75%以上の非酸化のグリセリン溶液にオゾンが400ppm以上溶存していることを特徴とする。   In order to solve the above-mentioned problems, the invention described in claim 1 is an ozone-dissolved glycerin solution, characterized in that ozone is dissolved in a non-oxidized glycerin solution of 75% or more in an amount of 400 ppm or more.

請求項1に記載の発明によれば、高濃度で非酸化のグリセリンにオゾンが高濃度で溶存しているため、殺菌効果を発揮するのに充分なオゾン濃度を長期間保持することができる。   According to the first aspect of the present invention, since ozone is dissolved in high concentration in non-oxidized glycerin, it is possible to maintain an ozone concentration sufficient for exhibiting a bactericidal effect for a long period of time.

請求項2に記載の発明は、オゾン溶存混合溶液であって、請求項1に記載のオゾン溶存グリセリン溶液を水、ワセリン、ポリエチレングリコールのいずれか1つと混合してなり、オゾンが80ppm以上溶存していることを特徴とする。   The invention according to claim 2 is an ozone-dissolved mixed solution, wherein the ozone-dissolved glycerin solution according to claim 1 is mixed with any one of water, petrolatum, and polyethylene glycol, and ozone is dissolved at 80 ppm or more. It is characterized by.

高濃度のグリセリンには肌への刺激性があるため、化粧水や美容液に利用する場合には、グリセリンの濃度を低下させる必要があるが、請求項2に記載の発明によれば、オゾン溶存グリセリン溶液を水、ワセリン、ポリエチレングリコールのいずれか1つと混合することで、グリセリンの刺激性を抑えることができる。また、オゾンが80ppm以上溶存しているため、充分な殺菌能力を発揮することができる。   Since the high concentration of glycerin is irritating to the skin, it is necessary to reduce the concentration of glycerin when it is used in a lotion or a cosmetic liquid. By mixing the dissolved glycerin solution with any one of water, petrolatum, and polyethylene glycol, the irritability of glycerin can be suppressed. Moreover, since ozone is dissolved 80 ppm or more, sufficient sterilizing ability can be exhibited.

なお、オゾンを水に溶解させた後にオゾン水にグリセリンを加えると、グリセリン濃度に依存して速やかに酸化力が消失するが、オゾンをグリセリンに溶存させた後にオゾン溶存グリセリン溶液を水で希釈しても酸化力が失われない。   In addition, when glycerin is added to ozone water after dissolving ozone in water, the oxidizing power disappears rapidly depending on the glycerin concentration, but after dissolving ozone in glycerin, the ozone-dissolved glycerin solution is diluted with water. But the oxidizing power is not lost.

また、ワセリンやポリエチレングリコールを高濃度のオゾンと気液接触させる場合には、有害な酸化物(過酸化物)が生じるが、高濃度のグリセリンに高濃度のオゾンを溶存させてから、ワセリンまたはポリエチレングリコールと混合する場合には、有害な酸化物(過酸化物)が生じない。したがって、オゾン溶存グリセリン溶液に、水、ワセリン、ポリエチレングリコールのいずれか1つを混合し、攪拌することで、酸化力の失われない、また有害な酸化物(過酸化物)を含まないオゾン溶存混合溶液を製造することができる。   In addition, when petrolatum or polyethylene glycol is brought into gas-liquid contact with high-concentration ozone, harmful oxides (peroxides) are produced, but after dissolving high-concentration ozone in high-concentration glycerin, petrolatum or When mixed with polyethylene glycol, no harmful oxide (peroxide) is produced. Therefore, by mixing any one of water, petrolatum, and polyethylene glycol with the ozone-dissolved glycerin solution and stirring, the ozone-dissolved ozone is not lost and does not contain harmful oxides (peroxides). A mixed solution can be produced.

請求項3に記載の発明は、請求項1に記載のオゾン溶存グリセリン溶液の製造方法であって、75%以上のグリセリン溶液に、オゾンを含むガスを気液接触させることを特徴とする。   Invention of Claim 3 is a manufacturing method of the ozone-dissolved glycerol solution of Claim 1, Comprising: Gas containing ozone is gas-liquid contacted to 75% or more of glycerol solutions, It is characterized by the above-mentioned.

請求項3に記載の発明によれば、75%以上のグリセリン溶液に、オゾンを含むガスを気液接触させることで、高濃度のグリセリンにオゾンを高濃度で溶存させたオゾン溶存グリセリン溶液を製造することができる。   According to the invention described in claim 3, an ozone-dissolved glycerin solution in which ozone is dissolved at a high concentration in glycerin is produced by bringing gas containing ozone into gas-liquid contact with 75% or more of the glycerin solution. can do.

請求項4に記載の発明は、請求項2に記載のオゾン溶存混合溶液の製造方法であって、請求項3に記載の製造方法で製造されたオゾン溶存グリセリン溶液と、水、ワセリン、ポリエチレングリコールのいずれか1つとを混合し、攪拌することを特徴とする。   Invention of Claim 4 is a manufacturing method of the ozone dissolved mixed solution of Claim 2, Comprising: The ozone dissolved glycerol solution manufactured with the manufacturing method of Claim 3, water, petrolatum, polyethyleneglycol Any one of the above is mixed and stirred.

請求項4に記載の発明によれば、請求項2に記載の発明と同様の効果を得ることができる。   According to the invention described in claim 4, the same effect as that of the invention described in claim 2 can be obtained.

請求項5に記載の発明は、オゾン溶存グリセリン溶液の保存方法であって、非酸化のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を、冷蔵保存または冷凍保存することを特徴とする。   The invention according to claim 5 is a method for preserving an ozone-dissolved glycerin solution, wherein the ozone-dissolved glycerin solution in which ozone is dissolved in a non-oxidized glycerin solution is refrigerated or frozen.

ここで、冷蔵保存とは、−5℃以上10℃以下で保存することであり、冷凍保存とは、−5℃以下で保存することである。なお、オゾン溶存グリセリン溶液のグリセリン濃度やオゾン濃度は任意である。   Here, refrigerated storage is storage at −5 ° C. or higher and 10 ° C. or lower, and frozen storage is storage at −5 ° C. or lower. In addition, the glycerol density | concentration and ozone density | concentration of an ozone dissolved glycerol solution are arbitrary.

請求項5に記載の発明によれば、非酸化のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を、冷蔵保存または冷凍保存することで、常温保存するよりもオゾン濃度を長期間、高濃度に維持することができる。   According to the invention described in claim 5, the ozone concentration glycerin solution, in which ozone is dissolved in the non-oxidized glycerin solution, can be stored in a refrigerator for a long time by refrigerated storage or frozen storage. The concentration can be maintained.

請求項6に記載の発明は、オゾン溶存グリセリン固化物であって、非酸化のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を冷却し、固化させたことを特徴とする。   The invention according to claim 6 is an ozone-dissolved glycerin solidified product, wherein the ozone-dissolved glycerin solution in which ozone is dissolved in a non-oxidized glycerin solution is cooled and solidified.

ここで、オゾン溶存グリセリン固化物は、冷却し、固化した状態のオゾン溶存グリセリン溶液であり、グリセリンが結晶化して固化していてもよいし、過冷却状態になり溶液全体の粘性が高くなって固化していてもよい。また、グリセリンが単独で固化していてもよいし、溶液を構成する他の成分とともに固化していてもよい。なお、オゾン溶存グリセリン溶液のグリセリン濃度やオゾン濃度は任意である。   Here, the ozone-dissolved glycerin solidified product is an ozone-dissolved glycerin solution in a cooled and solidified state, and the glycerin may be crystallized and solidified, or becomes supercooled and the viscosity of the whole solution becomes high. It may be solidified. Further, glycerin may be solidified alone, or may be solidified with other components constituting the solution. In addition, the glycerol density | concentration and ozone density | concentration of an ozone dissolved glycerol solution are arbitrary.

請求項6に記載の発明によれば、非酸化のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液が冷却されて固化しているため、液体の状態よりもオゾンを放出しにくく、オゾン濃度をより長期間、高濃度に維持することができる。   According to the invention described in claim 6, since the ozone-dissolved glycerin solution in which ozone is dissolved in the non-oxidized glycerin solution is cooled and solidified, the ozone concentration is less likely to be released than in the liquid state. Can be maintained at a high concentration for a longer period of time.

本発明によれば、高濃度のグリセリン溶液に高濃度のオゾンを溶存させているため、オゾン溶存グリセリン溶液中のオゾンの溶存濃度を、殺菌剤等に用いるのに充分な濃度で長期間維持することができる。   According to the present invention, since high-concentration ozone is dissolved in the high-concentration glycerin solution, the dissolved concentration of ozone in the ozone-dissolved glycerin solution is maintained for a long time at a concentration sufficient to be used as a disinfectant or the like. be able to.

また、オゾン溶存グリセリン溶液を、水、ワセリン、ポリエチレングリコールのいずれかと混合するため、酸化力の失われない、また有害な酸化物(過酸化物)を含まないオゾン溶存混合溶液を製造することができる。   Moreover, since the ozone-dissolved glycerin solution is mixed with water, petroleum jelly, or polyethylene glycol, it is possible to produce an ozone-dissolved mixed solution that does not lose its oxidizing power and does not contain harmful oxides (peroxides). it can.

また、オゾン溶存グリセリン溶液を冷蔵保存または冷凍保存することで、常温保存するよりもオゾン濃度を長期間、高濃度に維持することができる。また、オゾン溶存グリセリン溶液を冷却して固化することで、液体の状態よりもオゾンが放出されにくくし、オゾン濃度をより長期間、高濃度に維持することができる。   Further, by storing the ozone-dissolved glycerin solution in a refrigerated or frozen state, it is possible to maintain the ozone concentration at a high concentration for a long period of time compared with storing at normal temperature. Further, by cooling and solidifying the ozone-dissolved glycerin solution, ozone is less likely to be released than in a liquid state, and the ozone concentration can be maintained at a high concentration for a longer period.

以下、本発明の実施の形態について詳細に説明する。本発明のオゾン溶存グリセリン溶液は、高濃度のグリセリン溶液とオゾン濃度の高い気体とを気液接触させることで製造することができる。   Hereinafter, embodiments of the present invention will be described in detail. The ozone-dissolved glycerin solution of the present invention can be produced by gas-liquid contact between a high-concentration glycerin solution and a gas having a high ozone concentration.

オゾン濃度の高い気体は、例えば酸素ガスに無声放電することでオゾンを生成するオゾン発生装置で製造することができる。酸素ガスを用いる場合には、医療用の酸素ボンベを用いてもよいし、また酸素発生装置で製造された酸素ガスを用いてもよい。空気を用いると、窒素酸化物が生成される。空気を用いてオゾン濃度の高い気体を生成し、ヨウ化カリウム適定法でオゾン濃度を測定すると、ヨウ化カリウム消費量が見かけ上増加するが、これは窒素酸化物のためである。窒素酸化物は有害物質であるため、空気を用いる方法は実際の使用に適さない。   A gas having a high ozone concentration can be produced by an ozone generator that generates ozone by silent discharge to oxygen gas, for example. When oxygen gas is used, a medical oxygen cylinder may be used, or oxygen gas produced by an oxygen generator may be used. When air is used, nitrogen oxides are produced. When a gas having a high ozone concentration is generated using air and the ozone concentration is measured by a potassium iodide titration method, the consumption of potassium iodide is apparently increased because of nitrogen oxides. Since nitrogen oxides are harmful substances, the method using air is not suitable for actual use.

高濃度のグリセリン溶液としては、グリセリン濃度75%以上のグリセリン溶液を用いることができるが、日本薬局方品の84〜87重量%のグリセリンが好ましく、日本薬局方品のグリセリン濃度98%以上の濃グリセリンを用いることがより好ましい。また、濃度98.5%以上の精製グリセリンを用いることがさらに好ましい。グリセリン濃度が高いと、オゾンをより高濃度に溶存させることができるからである。   As the high-concentration glycerin solution, a glycerin solution having a glycerin concentration of 75% or more can be used, but 84 to 87% by weight of glycerin of the Japanese pharmacopoeia product is preferable, and the glycerin concentration of the Japanese pharmacopoeia product is 98% or more. More preferably, glycerin is used. Further, it is more preferable to use purified glycerin having a concentration of 98.5% or more. This is because if the glycerin concentration is high, ozone can be dissolved at a higher concentration.

高濃度のグリセリン溶液とオゾン濃度の高い気体とを気液接触させる方法としては、例えばタンクに高濃度(例えば98%以上)のグリセリン溶液を入れ、散気管を用いてタンク内にオゾン濃度の高い気体を微細な気泡として放出する方法がある。例えば、オゾン濃度80g/kL(約37000ppm)の気体を濃グリセリン中に約7日間曝気することにより、オゾン濃度約3000ppmのオゾン溶存グリセリン溶液を製造することができる。   As a method for bringing a high-concentration glycerin solution into contact with a gas having a high ozone concentration, for example, a high-concentration (for example, 98% or more) glycerin solution is placed in a tank, and a high concentration of ozone is contained in the tank using an air diffuser. There is a method for releasing gas as fine bubbles. For example, an ozone-dissolved glycerin solution having an ozone concentration of about 3000 ppm can be produced by aeration of a gas having an ozone concentration of 80 g / kL (about 37000 ppm) in concentrated glycerin for about 7 days.

オゾンの終濃度はグリセリン濃度に依存して定まり、前述の方法の場合、グリセリン濃度75%ではオゾンの終濃度は約400ppm、グリセリン濃度85%ではオゾンの終濃度は約500ppm、グリセリン濃度90%ではオゾンの終濃度は約1000ppm、グリセリン濃度98%ではオゾンの終濃度は約3000ppmとなる。   The final concentration of ozone is determined depending on the glycerin concentration. In the case of the above-described method, the final concentration of ozone is about 400 ppm at a glycerin concentration of 75%, the final concentration of ozone is about 500 ppm at a glycerin concentration of 85%, and the final concentration of glycerin is 90%. When the final concentration of ozone is about 1000 ppm and the glycerol concentration is 98%, the final concentration of ozone is about 3000 ppm.

最終的に得られるオゾン溶存グリセリン溶液は、グリセリン濃度75%以上でオゾン濃度400ppm以上であることが好ましく、グリセリン濃度80%以上でオゾン濃度500ppm以上であることがより好ましく、グリセリン濃度90%以上でオゾン濃度1000ppm以上であることがさらに好ましく、グリセリン濃度98%以上でオゾン濃度3000ppm以上であることが最も好ましい。グリセリンが高濃度であるほど、オゾンを高濃度にすることができ、殺菌効果及び創傷治癒効果を高めることができるとともに、オゾン濃度を長期間にわたり維持することができるからである。このように製造されたオゾン溶存グリセリン溶液は、オゾンの初期濃度が高濃度であり、後述するようにオゾン濃度の半減期が長くなり、殺菌剤として必要なオゾン濃度を長期間にわたり維持することができる。   The finally obtained ozone-dissolved glycerol solution preferably has a glycerol concentration of 75% or more and an ozone concentration of 400 ppm or more, more preferably a glycerol concentration of 80% or more and an ozone concentration of 500 ppm or more, and a glycerol concentration of 90% or more. The ozone concentration is more preferably 1000 ppm or more, and most preferably the glycerol concentration is 98% or more and the ozone concentration is 3000 ppm or more. This is because the higher the glycerin concentration, the higher the ozone concentration, the higher the bactericidal effect and the wound healing effect, and the longer the ozone concentration can be maintained. The ozone-dissolved glycerin solution produced in this way has a high initial concentration of ozone. As will be described later, the half-life of the ozone concentration becomes long, and the ozone concentration necessary as a disinfectant can be maintained over a long period of time. it can.

また、オゾン濃度の半減期が長いことからわかるように、このオゾン溶存グリセリン溶液から放出されるオゾンの量は極めて少ない。したがって、オゾン溶存グリセリン溶液の使用部位、到達部位においてオゾンを少しずつ長期間にわたり放出させることができる。また、放出されるオゾンの量が極めて少ないため、このオゾン溶存グリセリン溶液は、高濃度のオゾンが溶存しているのにもかかわらず、全くオゾン臭がしない。   Further, as can be seen from the long half-life of the ozone concentration, the amount of ozone released from this ozone-dissolved glycerin solution is extremely small. Therefore, ozone can be gradually released over a long period of time at the site where the ozone-dissolved glycerin solution is used and where it reaches. In addition, since the amount of ozone released is extremely small, this ozone-dissolved glycerin solution does not have an ozone odor at all even though high-concentration ozone is dissolved.

なお、オゾン溶存グリセリン溶液を−5℃以上10℃以下で冷蔵保存または−5℃以下で冷凍保存することで、オゾン溶存グリセリン溶液から放出されるオゾンの量をさらに少なくすることができ、常温保存するよりもオゾン濃度をより長期間、高濃度に維持することができる。   In addition, the amount of ozone released from the ozone-dissolved glycerin solution can be further reduced by storing the ozone-dissolved glycerin solution refrigerated at -5 ° C. or higher and 10 ° C. or frozen at -5 ° C. or lower. It is possible to maintain the ozone concentration at a high concentration for a longer period of time.

特に、オゾン溶存グリセリン溶液を冷却してオゾン溶存グリセリン固化物とした場合には、液体の状態よりもオゾンが放出されにくく、オゾン濃度をより長期間、高濃度に維持することができる。ここで、オゾン溶存グリセリン固化物は、冷却し、固化した状態のオゾン溶存グリセリン溶液であり、グリセリンが結晶化して固化していてもよいし、過冷却状態になり溶液全体の粘性が高くなっていてもよい。また、グリセリンが単独で固化していてもよいし、溶液を構成する他の成分とともに固化していてもよい。   In particular, when the ozone-dissolved glycerin solution is cooled to obtain an ozone-dissolved glycerin solidified product, ozone is less likely to be released than the liquid state, and the ozone concentration can be maintained at a high concentration for a longer period. Here, the ozone-dissolved glycerin solidified product is an ozone-dissolved glycerin solution in a cooled and solidified state. The glycerin may be crystallized and solidified, and the viscosity of the entire solution is increased due to a supercooled state. May be. Further, glycerin may be solidified alone, or may be solidified with other components constituting the solution.

ここで、グリセリン濃度75%以上でオゾン濃度400ppm以上のオゾン溶存グリセリン溶液に限らず、任意の濃度のオゾン溶存グリセリン溶液が、冷蔵保存または冷凍保存することでオゾン濃度をより長期間、高濃度に維持することができる。冷却してオゾン溶存グリセリン固化物とする場合も同様である。   Here, not only the ozone-dissolved glycerin solution having a glycerin concentration of 75% or more and an ozone concentration of 400 ppm or more, an ozone-dissolved glycerin solution of any concentration can be stored at a high concentration for a longer period of time by refrigerated storage or frozen storage. Can be maintained. The same applies to the case of cooling to obtain an ozone-dissolved glycerin solidified product.

なお、オゾンを濃グリセリンに溶存させることで、グリセリンが酸化されることも想定されるため、今回、原料グリセリン及びオゾン溶存グリセリン溶液の1H−NMRスペクトル及び13C−NMRスペクトルを計測し、比較した。その結果、原料グリセリンのスペクトルと、オゾン溶存グリセリン溶液のスペクトルとの間に差異はなく、グリセリンの酸化物は検出されなかった。したがって、濃グリセリンに高濃度のオゾンを溶存させても、グリセリンはオゾンにより酸化されないことがわかった。 In addition, since it is also assumed that glycerol is oxidized by dissolving ozone in concentrated glycerol, this time, 1 H-NMR spectrum and 13 C-NMR spectrum of raw material glycerol and ozone-dissolved glycerol solution were measured and compared. did. As a result, there was no difference between the spectrum of the raw material glycerin and the spectrum of the ozone-dissolved glycerin solution, and no glycerin oxide was detected. Therefore, it was found that even when high-concentration ozone was dissolved in concentrated glycerin, glycerin was not oxidized by ozone.

また、気体のオゾンの自然半減期は2時間程度とされているが、オゾン溶存グリセリン溶液中のオゾンの半減期は、後述するように、それよりもはるかに長いものであった。したがって、オゾン溶存グリセリン溶液中のオゾンは気泡の状態で存在するのではなく、グリセリンに溶存しているものと推定される。実際にオゾン溶存グリセリン溶液を生成した直後には、多数の気泡を肉眼で観察できるが、数時間放置するとこれらの気泡は観察されなくなる。   The natural half-life of gaseous ozone is about 2 hours, but the half-life of ozone in the ozone-dissolved glycerin solution is much longer than that, as will be described later. Therefore, it is presumed that ozone in the ozone-dissolved glycerin solution does not exist in the form of bubbles but is dissolved in glycerin. Immediately after actually producing the ozone-dissolved glycerin solution, a large number of bubbles can be observed with the naked eye, but if left for several hours, these bubbles are not observed.

なお、オゾン溶存グリセリン溶液は用途によってはそのまま使用することもできるが、化粧水や美容液に利用する場合には、高濃度のグリセリンには肌への刺激性があるため、グリセリンの濃度を20%以下にすることが好ましい。このため、オゾン溶存グリセリン溶液に適当な希釈剤を混合して希釈することが好ましい。   The ozone-dissolved glycerin solution can be used as it is depending on the application. However, when used in a lotion or a cosmetic liquid, the high concentration of glycerin has irritation to the skin. % Or less is preferable. For this reason, it is preferable to mix and dilute a suitable diluent with ozone solution glycerol solution.

このような希釈剤としては、オゾンにより酸敗しにくいものが適しており、水、ワセリン、ポリエチレングリコールなどが適している。水を希釈剤とする場合は、純水または超純水を使用することが好ましい。水に不純物が混入していると、オゾンに酸化されて皮膚に刺激を与えたり薬効を低下させたりする酸化物(過酸化物)が生成される恐れがあるためである。   As such a diluent, those which are not easily oxidized by ozone are suitable, and water, petrolatum, polyethylene glycol and the like are suitable. When water is used as a diluent, it is preferable to use pure water or ultrapure water. This is because if water is contaminated with impurities, it may be oxidized to ozone to generate oxides (peroxides) that irritate the skin or reduce the efficacy.

ワセリンを使用する場合は、不純物が少なく酸敗されにくい精製ワセリンを用いることが好ましい。不純物があるとオゾンに酸化されて皮膚に刺激を与えたり薬効を低下させたりする酸化物(過酸化物)が生成されるからである。このような精製ワセリンとしては、丸石製薬社製のプロペト(登録商標)や、日興リカ社製のサンホワイト(登録商標)等を用いることができる。   When petrolatum is used, it is preferable to use purified petrolatum that has few impurities and is not easily degraded. This is because, if there is an impurity, it is oxidized to ozone, and an oxide (peroxide) is generated that irritate the skin or reduce the medicinal effect. As such refined petrolatum, Propeto (registered trademark) manufactured by Maruishi Pharmaceutical Co., Ltd., Sun White (registered trademark) manufactured by Nikko Rica Co., Ltd., or the like can be used.

ポリエチレングリコールを使用する場合は、日本薬局方で定められたマクロゴール軟膏を用いることが望ましい。マクロゴール軟膏は、液体のマクロゴール400と固体のマクロゴール4000とをほぼ1:1で混合したものであるが、用途に応じて粘度を調整するために混合比を適宜変更してもよい。また、粘度を調整するために高分子剤を添加してもよい。マクロゴールには吸湿性があるため、グリセリンと混合することで保湿性が高い軟膏とすることができる。   When polyethylene glycol is used, it is desirable to use macrogol ointment defined by the Japanese Pharmacopoeia. Macrogol ointment is a mixture of liquid macrogol 400 and solid macrogol 4000 in a ratio of approximately 1: 1, but the mixing ratio may be changed as appropriate in order to adjust the viscosity according to the application. A polymer agent may be added to adjust the viscosity. Since macrogol is hygroscopic, it can be made into an ointment with high moisture retention by mixing with glycerin.

これらの希釈剤でオゾン溶存グリセリン溶液を希釈したオゾン溶存混合溶液は、オゾン濃度が80ppm以上であることが好ましい。オゾン濃度が80ppm以上であれば、殺菌能力を発揮することができる。また、オゾン濃度が100ppm以上であれば、より殺菌能力を発揮することができる。さらに、オゾン濃度が500ppm以上であれば、創傷治癒効果を得ることができ、オゾン濃度が1000ppm以上であれば、後述するように、優れた創傷治癒効果を発揮することができる。   The ozone-dissolved mixed solution obtained by diluting the ozone-dissolved glycerin solution with these diluents preferably has an ozone concentration of 80 ppm or more. If the ozone concentration is 80 ppm or more, the sterilizing ability can be exhibited. Moreover, if ozone concentration is 100 ppm or more, sterilization ability can be exhibited more. Furthermore, if the ozone concentration is 500 ppm or more, a wound healing effect can be obtained, and if the ozone concentration is 1000 ppm or more, an excellent wound healing effect can be exhibited as described later.

上記のオゾン溶存混合溶液もまた、−5℃以上10℃以下で冷蔵保存または−5℃以下で冷凍保存することで、オゾン溶存混合溶液から放出されるオゾンの量をさらに少なくすることができ、常温保存するよりもオゾン濃度をより長期間、高濃度に維持することができる。   The above ozone-dissolved mixed solution can also be further reduced in the amount of ozone released from the ozone-dissolved mixed solution by refrigerated storage at −5 ° C. or more and 10 ° C. or less or frozen storage at −5 ° C. or less. The ozone concentration can be maintained at a high concentration for a longer period than when stored at room temperature.

また、オゾン溶存混合溶液も、オゾン溶存グリセリン溶液と同様に、冷却してオゾン溶存グリセリン固化物とすることができる。オゾン溶存グリセリン固化物とした場合には、液体の状態よりもオゾンが放出されにくく、オゾン濃度をより長期間、高濃度に維持することができる。   Further, the ozone-dissolved mixed solution can be cooled to be an ozone-dissolved glycerin solidified product, similarly to the ozone-dissolved glycerin solution. When the ozone-dissolved glycerin solidified product is used, ozone is less likely to be released than the liquid state, and the ozone concentration can be maintained at a high concentration for a longer period.

濃グリセリンとオゾンとを気液接触させ、オゾン溶存グリセリン溶液を製造した。ここで、濃グリセリンとは、日本薬局方品の98%以上の濃度のグリセリンを意味する。   Concentrated glycerin and ozone were brought into gas-liquid contact to produce an ozone-dissolved glycerin solution. Here, the concentrated glycerin means glycerin having a concentration of 98% or more of Japanese Pharmacopoeia.

接触槽として、容量50Lのテフロン(登録商標)製タンクを用いた。タンクの底面に散気管を設置し、オゾンを微細な気泡としてタンク内に供給することができるようにした。オゾン発生装置には、90%以上の濃度の酸素を原料として毎時100gのオゾン発生能力を有する無声放電式オゾン発生装置を使用した。   A Teflon (registered trademark) tank having a capacity of 50 L was used as the contact tank. A diffuser tube was installed on the bottom of the tank so that ozone could be supplied into the tank as fine bubbles. As the ozone generator, a silent discharge type ozone generator having an ozone generation capacity of 100 g / h using oxygen having a concentration of 90% or more as a raw material was used.

タンクに22kgの濃グリセリンを入れ、オゾン発生装置に毎分20Lの酸素を送り込み、発生したオゾンを含む気体を散気管からタンク内に7日間放出し、終濃度3000ppmのオゾン濃度のオゾン溶存グリセリン溶液を得た。   Put 22kg of concentrated glycerin into the tank, send 20L of oxygen per minute into the ozone generator, release the gas containing the generated ozone from the diffuser into the tank for 7 days, and the ozone dissolved glycerin solution with a final concentration of 3000ppm ozone concentration Got.

得られたオゾン溶存グリセリン溶液を常温、冷蔵(約5℃)、冷凍(約−20℃)のいずれかで保存し、オゾン濃度の半減期を計測した。オゾン濃度の測定にはヨウ化カリウム適定法を用いた。   The obtained ozone-dissolved glycerin solution was stored at room temperature, refrigerated (about 5 ° C.), or frozen (about −20 ° C.), and the half-life of the ozone concentration was measured. The potassium iodide titration method was used for the measurement of the ozone concentration.

得られたオゾン溶存グリセリン溶液を常温で保存したところ、約6ヶ月でオゾン濃度が半減した。また、冷蔵時には、約16ヶ月でオゾン濃度が半減した。また、3年間冷凍保存したところ、オゾン濃度の変化率は98%であり、ほとんど変化しなかった。これは、冷凍することでオゾン溶存グリセリン溶液のグリセリンが結晶化したため、あるいは溶液全体の粘性が高くなったため、液体の状態よりもオゾンが放出されにくくなったと考えられる。   When the obtained ozone-dissolved glycerin solution was stored at room temperature, the ozone concentration was halved in about 6 months. When refrigerated, the ozone concentration halved in about 16 months. When stored frozen for 3 years, the ozone concentration change rate was 98%, showing almost no change. This is probably because the glycerin of the ozone-dissolved glycerin solution was crystallized by freezing or the viscosity of the whole solution was increased, so that ozone was less likely to be released than in the liquid state.

濃グリセリンから上記製造方法にて製造されたオゾン溶存グリセリン溶液(以下、オゾンジェルという)及びこれにマクロゴール軟膏を混合したオゾン溶存混合溶液(以下、オゾン軟膏という)と、強電解酸性ジェル、電解酸性機能水と比較検討した。   Ozone-dissolved glycerin solution (hereinafter referred to as ozone gel) produced from concentrated glycerin by the above-described production method, ozone-dissolved mixed solution (hereinafter referred to as ozone ointment) in which macrogol ointment is mixed with this, strong electrolytic acid gel, electrolysis A comparison was made with acidic functional water.

〔実験材料〕
4週齢雄性Wistar系ラットを16匹、オゾン軟膏(VMC社製)、比較対照としてオゾンジェル(VMC社製)、強電解酸性ジェル(MIZ社製)、電解酸性機能水(OXILIZER(登録商標)、三浦電子社製)を用いた。
[Experimental material]
16 4-week-old male Wistar rats, ozone ointment (manufactured by VMC), ozone gel (manufactured by VMC), strong electrolytic acid gel (manufactured by MIZ), and electrolytic acid functional water (OXILIZER (registered trademark)) as comparative controls Manufactured by Miura Electronics Co., Ltd.).

オゾン軟膏及びオゾンジェルは、ともにオゾンの溶存濃度が1000ppmに調整してあるものを用いた。強電解酸性ジェルはpH2.14、酸化還元電位463mV、有効塩素濃度0ppmのソフトタイプを用い、電解酸性機能水はpH2.14、酸化還元電位1157mV、有効塩素濃度37.33ppmに調整したものを用いた。   Both ozone ointment and ozone gel were used in which the dissolved concentration of ozone was adjusted to 1000 ppm. Strong electrolytic acid gel is soft type with pH 2.14, oxidation reduction potential 463 mV, effective chlorine concentration 0 ppm, and electrolytic acid functional water is adjusted to pH 2.14, oxidation reduction potential 1157 mV, effective chlorine concentration 37.33 ppm. It was.

〔実験方法〕
エチルエーテルによりラットに麻酔を施した後、背部の皮膚をヒビテンにて消毒し剃毛した。その部位にデルマパンチ(スティーフェル・ラボラトリウム社製)を用いて、直径5mm、深さ約1mmの創傷部位を4箇所、作製した。各創傷部位に1日2回(AM9:00、PM9:00)、オゾン軟膏、オゾンジェル、強電解酸性ジェル、電解酸性機能水をそれぞれ塗布した。
〔experimental method〕
After anesthetizing the rat with ethyl ether, the back skin was disinfected with hibiten and shaved. Four wound sites having a diameter of 5 mm and a depth of about 1 mm were prepared using a derma punch (manufactured by Stiefel Laboratorium) at the site. Ozone ointment, ozone gel, strong electrolytic acid gel, and electrolytic acidic functional water were applied to each wound site twice a day (AM 9:00, PM 9:00).

創傷部位作製1、3、5、7日目にラットの創傷部位の直径を計測し、その後直ちに屠殺し試料を採取した。なお、直径の計測は1つの少々部位につき4箇所で行い、その平均値を計測結果とした。   On the first, third, fifth, and seventh days after preparation of the wound site, the diameter of the wound site of the rat was measured, and then immediately sacrificed and a sample was taken. In addition, the measurement of a diameter was performed in four places per one part, and the average value was made into the measurement result.

採取した試料をパラフィン包埋し、切片を作製した後、HE染色を施し、試料の上皮の再生度、肉芽組織の形成度を観察した。また、アザン染色を行い、創傷治癒過程における膠原繊維の増殖度を検討した。   The collected sample was embedded in paraffin and sliced, and then stained with HE to observe the degree of epithelial regeneration and granulation tissue formation. Azan staining was also performed to examine the degree of collagen fiber growth during the wound healing process.

〔結果及び考察〕
<<肉眼的な観察>>
<1日例>
創傷部位の直径の縮小率は、電解酸性機能水では98.1%、強電解酸性ジェルでは93.5%、オゾンジェルでは98.0%、オゾン軟膏では94.3%であったが、有意差は認められなかった。
[Results and discussion]
<< Macroscopic observation >>
<One day example>
The reduction rate of the wound site diameter was 98.1% for electrolytic acid functional water, 93.5% for strong electrolytic acid gel, 98.0% for ozone gel, and 94.3% for ozone ointment. There was no difference.

<3日例>
創傷部位の直径の縮小率は、電解酸性機能水では82.5%、強電解酸性ジェルでは82.5%、オゾンジェルでは80.5%、オゾン軟膏では86.5%であったが、有意差は認められなかった。
<3 days example>
The reduction rate of the wound site diameter was 82.5% for electrolytic acid functional water, 82.5% for strong electrolytic acid gel, 80.5% for ozone gel, and 86.5% for ozone ointment. There was no difference.

<5日例>
創傷部位の直径の縮小率は、電解酸性機能水では70.5%、強電解酸性ジェルでは66.5%、オゾンジェルでは63.5%、オゾン軟膏では63.0%であったが、有意差は認められなかった。
<Example of 5 days>
The reduction rate of the wound site diameter was 70.5% for electrolytic acid functional water, 66.5% for strong electrolytic acid gel, 63.5% for ozone gel, and 63.0% for ozone ointment. There was no difference.

<7日例>
創傷部位の直径の縮小率は、電解酸性機能水では57.5%、強電解酸性ジェルでは51.0%、オゾンジェルでは44.0%、オゾン軟膏では41.5%であった。電解酸性機能水とオゾン軟膏、電解酸性機能水とオゾンジェル、強電解酸性ジェルとオゾン軟膏の間に有意差が認められた。
<Example of 7 days>
The reduction rate of the wound site diameter was 57.5% for electrolytic acid functional water, 51.0% for strong electrolytic acid gel, 44.0% for ozone gel, and 41.5% for ozone ointment. Significant differences were observed between electrolytic acidic functional water and ozone ointment, electrolytic acidic functional water and ozone gel, strong electrolytic acidic gel and ozone ointment.

<<HE染色における組織学的観察>>
<1日例、3日例>
明らかな差異は認められなかった。
<< Histological observation in HE staining >>
<1 day example, 3 day example>
There were no obvious differences.

<5日例>
3日例と比較し、電解酸性機能水では、肉芽組織の再生を認め、フィブリン層の吸収促進が見られた。強電解酸性ジェルでは、上皮下に炎症性細胞浸潤を伴う肉芽組織の形成が見られ、僅かではあるが創傷中心に向かう基底細胞の再生と繊維形成が認められた。オゾンジェルでは、炎症性細胞浸潤を伴う肉芽組織の形成、創傷部辺縁より上皮の再生が認められた。オゾン軟膏では、肉芽組織内の炎症性細胞浸潤がやや消退しており、比較的良好な上皮の再生が認められた。
<Example of 5 days>
Compared to the 3-day example, in the electrolytic acid functional water, regeneration of the granulation tissue was observed, and the absorption promotion of the fibrin layer was observed. In the strongly electrolyzed acidic gel, granulation tissue accompanied by inflammatory cell infiltration was observed in the subepithelium, and regeneration of basal cells and fiber formation toward the wound center were observed to a slight extent. With ozone gel, granulation tissue formation with inflammatory cell infiltration and epithelial regeneration from the wound margin were observed. In ozone ointment, inflammatory cell infiltration in the granulation tissue was slightly relieved, and relatively good epithelial regeneration was observed.

<7日例>
電解酸性機能水では肉芽組織はやや消退し、郵送細胞の減少が見られた。強電解酸性ジェルでは上皮下の炎症細胞浸潤はほぼ消退し、線維性結合組織で形成され、毛細血管の形成が見られた。オゾンジェル、オゾン軟膏では、上皮下の炎症性細胞はほぼ消退しており、毛細血管の豊富な線維性結合組織が形成され、上皮の再生も良好であった。
<Example of 7 days>
In the electrolyzed acidic functional water, the granulation tissue disappeared slightly, and the number of mail cells was reduced. In the strong electrolyzed acidic gel, the inflammatory cell infiltration in the subepithelium was almost abolished, formed with fibrous connective tissue, and the formation of capillaries was observed. In the case of ozone gel and ozone ointment, inflammatory cells in the subepithelium were almost eliminated, fibrous connective tissue rich in capillaries was formed, and epithelial regeneration was also good.

<<アザン染色における組織学的所見>>
<1日例、3日例>
明らかな差異は認められなかった。
<< Histological findings in Azan staining >>
<1 day example, 3 day example>
There were no obvious differences.

<5日例、7日例>
線維性結合組織の再生度は、オゾン軟膏、オゾンジェル、強電解酸性ジェル、電解酸性機能水の順に良好であることが確認された。
<5 days, 7 days>
It was confirmed that the regeneration degree of the fibrous connective tissue was good in the order of ozone ointment, ozone gel, strong electrolytic acid gel, and electrolytic acidic functional water.

以上の結果より、オゾン軟膏は、オゾンジェル、強電解酸性ジェルと比較して、肉眼的な観点からほぼ同様な治療経過を呈した。上皮の再生度についても、組織学的にはオゾン軟膏が最も良好で、次いでオゾンジェル、強電解酸性ジェル、電解酸性機能水の順に良好であった。オゾン軟膏は強電解酸性ジェル、オゾンジェルのように創傷部への刺激がなく、塗布しやすい長所を有しているので、創傷部への治療薬として応用できる可能性が示唆された。   From the above results, ozone ointment exhibited almost the same treatment course from the macroscopic viewpoint as compared with ozone gel and strong electrolytic acid gel. Regarding the degree of epithelial regeneration, ozone ointment was the best histologically, followed by ozone gel, strong electrolytic acidic gel, and electrolytic acidic functional water. Ozone ointment has the merit that it is easy to apply because there is no irritation to the wound part like strong electrolysis acidic gel and ozone gel, suggesting the possibility that it can be applied as a therapeutic agent to the wound part.

Claims (6)

75%以上の非酸化のグリセリン溶液にオゾンが400ppm以上溶存していることを特徴とするオゾン溶存グリセリン溶液。   An ozone-dissolved glycerin solution, wherein ozone is dissolved in a non-oxidized glycerin solution of 75% or more in an amount of 400 ppm or more. 請求項1に記載のオゾン溶存グリセリン溶液を水、ワセリン、ポリエチレングリコールのいずれか1つと混合してなり、オゾンが80ppm以上溶存していることを特徴とするオゾン溶存混合溶液。   An ozone-dissolved mixed solution, wherein the ozone-dissolved glycerin solution according to claim 1 is mixed with any one of water, petrolatum, and polyethylene glycol, and ozone is dissolved at 80 ppm or more. 請求項1に記載のオゾン溶存グリセリン溶液の製造方法であって、75%以上のグリセリン溶液に、オゾンを含むガスを気液接触させることを特徴とするオゾン溶存グリセリン溶液の製造方法。   The method for producing an ozone-dissolved glycerin solution according to claim 1, wherein gas containing ozone is brought into gas-liquid contact with 75% or more of the glycerin solution. 請求項2に記載のオゾン溶存混合溶液の製造方法であって、請求項3に記載の製造方法で製造されたオゾン溶存グリセリン溶液と、水、ワセリン、ポリエチレングリコールのいずれか1つとを混合し、攪拌することを特徴とするオゾン溶存混合溶液の製造方法。   A method for producing an ozone-dissolved mixed solution according to claim 2, wherein the ozone-dissolved glycerin solution produced by the production method according to claim 3 is mixed with any one of water, petrolatum, and polyethylene glycol. A method for producing an ozone-dissolved mixed solution characterized by stirring. 非酸化のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を、冷蔵保存または冷凍保存することを特徴とするオゾン溶存グリセリン溶液の保存方法。   A method for preserving an ozone-dissolved glycerin solution, wherein the ozone-dissolved glycerin solution in which ozone is dissolved in a non-oxidized glycerin solution is stored in a refrigerator or frozen. 非酸化のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を冷却し、固化させたことを特徴とするオゾン溶存グリセリン固化物。   An ozone-dissolved glycerin solidified product obtained by cooling and solidifying an ozone-dissolved glycerin solution in which ozone is dissolved in a non-oxidized glycerin solution.
JP2004044088A 2004-02-20 2004-02-20 Method for producing ozone-dissolved glycerin solution Expired - Lifetime JP4677192B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2004044088A JP4677192B2 (en) 2004-02-20 2004-02-20 Method for producing ozone-dissolved glycerin solution
TW094104998A TW200603819A (en) 2004-02-20 2005-02-18 Ozone dissolved glycerol solution, ozone dissolved glycerol solidified material and ozone dissolved mixed solution, method for producing ozone dissolved glycerol solution, ozone dissolved mixed solution and preserving ozone dissolved glycerol solution
PCT/JP2005/002570 WO2005079818A1 (en) 2004-02-20 2005-02-18 Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004044088A JP4677192B2 (en) 2004-02-20 2004-02-20 Method for producing ozone-dissolved glycerin solution

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010264594A Division JP5222344B2 (en) 2010-11-29 2010-11-29 Ozone-dissolved glycerin solution, ozone-dissolved glycerin solidified product, ozone-dissolved mixed solution, method for producing ozone-dissolved glycerin solution, method for producing ozone-dissolved mixed solution, and method for storing ozone-dissolved glycerin solution

Publications (3)

Publication Number Publication Date
JP2005232094A true JP2005232094A (en) 2005-09-02
JP2005232094A5 JP2005232094A5 (en) 2010-01-21
JP4677192B2 JP4677192B2 (en) 2011-04-27

Family

ID=34879328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004044088A Expired - Lifetime JP4677192B2 (en) 2004-02-20 2004-02-20 Method for producing ozone-dissolved glycerin solution

Country Status (3)

Country Link
JP (1) JP4677192B2 (en)
TW (1) TW200603819A (en)
WO (1) WO2005079818A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007145493A1 (en) * 2006-06-16 2007-12-21 Hwa Jeong Ryu Disinfectant having ozone
JP2009001575A (en) * 2008-06-23 2009-01-08 Ozotech:Kk Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)
WO2019098241A1 (en) * 2017-11-16 2019-05-23 株式会社メディプラス製薬 Pharmaceutical composition for mastitis, and medical treatment method

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007030103A1 (en) * 2007-06-28 2009-01-02 Bode Chemie Gmbh & Co. Kg Use of a synergistic composition as a therapeutic or cosmetic agent
CN105833279B (en) * 2016-05-30 2021-06-22 傅远桥 External-use medicine composition for treating various wound surfaces of skin and preparation method thereof
CN110559189A (en) * 2019-08-20 2019-12-13 安徽氧趣生物科技有限公司 Preparation method of dimer and polymer ozone ointment
JP2023518298A (en) * 2020-03-19 2023-04-28 オンザ・コーポレイション Delivery of gas-phase antimicrobials by injected crystalline and porous solids
IT202100025622A1 (en) * 2021-10-07 2023-04-07 Roberto Albertelli METHOD AND EQUIPMENT FOR PRODUCING A TREATMENT SOLUTION AND ADMINISTRING SAID SOLUTION TO A BIOLOGICAL SYSTEM

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05301819A (en) * 1992-04-22 1993-11-16 Nippon Nature Roman:Kk Antiphlogistic agent for atopic dermatitis, apparatus for producing the same antiphlogistic agent and its production
JPH10139645A (en) * 1996-11-14 1998-05-26 Merubuaisu:Kk Ozone-including viscous substance and its generator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100455A2 (en) * 2001-06-08 2002-12-19 Baylor College Of Medicine Use of ozone for the prevention of infection caused by medical devices
JP2003055107A (en) * 2001-08-10 2003-02-26 Vmc Co Ltd Water-soluble germicide and method for producing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05301819A (en) * 1992-04-22 1993-11-16 Nippon Nature Roman:Kk Antiphlogistic agent for atopic dermatitis, apparatus for producing the same antiphlogistic agent and its production
JPH10139645A (en) * 1996-11-14 1998-05-26 Merubuaisu:Kk Ozone-including viscous substance and its generator

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007145493A1 (en) * 2006-06-16 2007-12-21 Hwa Jeong Ryu Disinfectant having ozone
JP2009525974A (en) * 2006-06-16 2009-07-16 株式会社E・テック Disinfectant containing ozone
JP2009001575A (en) * 2008-06-23 2009-01-08 Ozotech:Kk Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)
WO2019098241A1 (en) * 2017-11-16 2019-05-23 株式会社メディプラス製薬 Pharmaceutical composition for mastitis, and medical treatment method
JPWO2019098241A1 (en) * 2017-11-16 2020-11-19 株式会社メディプラス製薬 Pharmaceutical composition for mastitis and treatment method

Also Published As

Publication number Publication date
JP4677192B2 (en) 2011-04-27
TW200603819A (en) 2006-02-01
WO2005079818A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
US7393522B2 (en) Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
EP1162176B1 (en) Electrolyzed water of anode side and process for production thereof
WO2005079818A1 (en) Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss
JP4369530B2 (en) Dental sterilizing water, method for producing the same, and device for producing the same
WO2009125297A2 (en) Method of producing composition of hypochlorous acid and use thereof
Rastinfard et al. Aqueous decomposition behavior of solid peroxides: effect of pH and buffer composition on oxygen and hydrogen peroxide formation
AU2003251547A1 (en) Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
TW201016136A (en) Methods for treating oral cavity infections with chlorine dioxide
EP3312305B1 (en) Hypochlorous acid production
KR20110139225A (en) Nonaqueous chlorine dioxide-generating compositions and methods related thereto
US20130323326A1 (en) Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site
WO2018161938A1 (en) Gynecological vaginal wash for adjusting female vaginal microecology and preparation method thereof
JP2005232094A5 (en)
WO2010004699A1 (en) Agent for eliminating bad breath and method for producing the same
KR20160042209A (en) Method of manufacturing ozonized composition of oil, and ozonized composition of oil manufactured by using the same
JP5222344B2 (en) Ozone-dissolved glycerin solution, ozone-dissolved glycerin solidified product, ozone-dissolved mixed solution, method for producing ozone-dissolved glycerin solution, method for producing ozone-dissolved mixed solution, and method for storing ozone-dissolved glycerin solution
JP2004261656A (en) Manufacturing method for mixed electrolytic water
JPH06227956A (en) Cosmetic or medicinal composition
CN111467266B (en) Ozone nano-bubble gargle and preparation method thereof
CN113907072A (en) Preparation method of high-precision weak acid hypochlorite disinfectant
RU2189217C1 (en) Method for producing aqueous antiseptic solution for locally treating abscesses and phlegmons
US20150209470A1 (en) Oxygenated Oil Ointment
KR20220010873A (en) Hydrogen Water Mask Pack Composition
WO2003057261A1 (en) Method of supplying aqueous solution for sterilization and disinfection and method of using the same

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060822

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20060822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070131

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070131

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091130

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20091130

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20091216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100601

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101129

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20101224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110125

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110131

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140204

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4677192

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term